GE Medical completes purchase of Mecon
GE Medical Systems had finalized its acquisition of Mecon, a developer of data mining and Internet-based benchmarking products for the healthcare field. Mecon, of San Ramon, CA, will now operate as a wholly owned subsidiary of GE. As a result of the
GE Medical Systems had finalized its acquisition of Mecon, a developer of data mining and Internet-based benchmarking products for the healthcare field. Mecon, of San Ramon, CA, will now operate as a wholly owned subsidiary of GE. As a result of the merger, Mecon shareholders will receive 0.081 shares of GE stock for each share of Mecon stock held at the close of the merger, plus cash for any fractional shares. David Allinson, Mecons CFO, will assume the role of president and CEO, while Vasu Devan, president and CEO of Mecon since the company was founded, will continue in an advisory capacity.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
